| ID | Sequence | Length | GC content |
|---|---|---|---|
| LINC00968:4 | AAAGCAAUGAUAAAUAUUUGAGAUGCUGAACUUUUUAAUACUUACAUUC… | 553 nt | 0.4792 |
| LINC00968:5 | AUAUUUGAGAUGCUGAACUUUUUAAUACUUACAUUCUUAAGUUUUUCAA… | 2366 nt | 0.3922 |
| LINC00968:6 | UGGCAUUCCUGCCCUUGGCAGUGUGAGAUGGAAGAUGAUGUCGCAAGGG… | 2586 nt | 0.4138 |
| LINC00968:7 | AGUGUGAGAUGGAAGAUGAUGUCGCAAGGGUGGAGCCCAGUUGACAGGA… | 564 nt | 0.4521 |
| LINC00968:8 | GGAAGAUGAUGUCGCAAGGGUGGCCGAGAAGCAGCUGGGCUGAGCUGCU… | 2623 nt | 0.4072 |
| LINC00968:9 | GGAAGAUGAUGUCGCAAGGGUGGCCGAGAAGCAGCUGGGCUGAGCUGCU… | 2176 nt | 0.3989 |
No relevant information is available at the moment.
A study in humans demonstrated that the LINC00968 was upregulated in the subcutaneous adipose tissue of heavier co-twins within BMI-discordant monozygotic twin pairs [Muniandy et al. DOI:10.1038/ijo.2017.95]. A subsequent human intervention study found the LINC00968 was downregulated during short-term weight loss in obese participants, indicating its expression changes are reciprocal to those observed in acquired obesity [Bollepalli et al. DOI:10.1038/ijo.2017.245].